Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed
Conditions studied: Corneal Endothelial Cell Loss
In brief
The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
Key facts
- Study ID
- NCT02138266
- Run by
- Topcon Medical Systems, Inc.
- People needed
- 65
- Starts
- 2014-02-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2022-06-08
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Andover Eye Associates — Andover, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.